DF Maixner, AP Hermida… - American Journal of …, 2011 - Am Psychiatric Assoc ... 4). In a recent small study of thirteen patients, a rocuronium dose of 0.3 mg/kg was used in a cross-over design with succinylcholine (4). Rocuronium is a nondepolarizingmusclerelaxant with an action onset time of 1–2 minutes, although time to peak action tends to be longer. ...
RE Johnstone, RL Katz… - Anesthesiology, 2011 - journals.lww.com ... seemingly recovered from their anesthetics. Because administration of neostigmine restored ventilation in these patients, respiratory depression was diagnosed due to nondepolarizingmusclerelaxants. Although a rebound effect of ... Cited by 1 - Related articles - All 4 versions
[PDF] from dovepress.comL Bollag, CD Kent, P Richebé… - Local and Regional …, 2011 - dovepress.com ... pathology and expected respiratory insufficiency. The nondepolarizingmuscle relaxant rocuronium was given in four cases, including this one, and antagonized with neostigmine. However, SMA patients with their underlying ... Related articles - View as HTML - All 3 versions
[HTML] from omicsonline.orgC Shingu, T Nishida, S Hagiwara… - J Anesthe Clinic …, 2011 - omicsonline.org ... During general anesthesia, the normal amount of nondepolarizing neuromuscular blocker has prolonged effects in patients with myasthenia gravis ... perioperative period [3]. In the present cases, we used a muscle relaxation monitor perioperatively to minimize musclerelaxant use ... Related articles - Cached - All 2 versions
Y Kogashiwa, N Oishi, K Yamauchi… - Auris Nasus Larynx, 2011 - Elsevier ... Many reports have documented massive hyperkalemia and cardiac arrest secondary to the administration of nondepolarizingmusclerelaxants (succinylcholine) in patients with various neuromuscular disorders, including ALS [9]. Thus, in the anesthetic management of a patient ... Related articles - All 2 versions